- Hong
Kong Banks | NEUTRAL
- Chongqing
Rural Commercial Bank (3618 HK) | TP Revision
- China
Auto OEM | NEUTRAL
- MGM
China Holdings (2282 HK) | Results Review
- ICICI
Bank (ICICIBC IN) | Results Review
- Yes
Bank (YES IN) | Results Review
- Kalbe
Farma (KLBF IJ) | Results Review
- ACE
Hardware (ACES IJ) | Results Review
- Gudang
Garam (GGRM IJ) | Results Review
- Indofood
CBP (ICBP IJ) | Results Review
- Erajaya
Swasembada (ERAA IJ) | Results Review
- Mitra
Adiperkasa (MAPI IJ) | Results Review
- Lippo
Karawaci (LPKR IJ) | Results Review
- Matahari
Putra Prima (MPPA IJ) | Results Review
- Ramayana
Lestari (RALS IJ) | Results Review
- Tenaga
Nasional (TNB MK) | Results Review
- Malaysia
Banking | NEUTRAL
- Felda
Global Ventures (FGV MK) | Company Update
- SMRT
(MRT SP) | Results Review
- Kasikornbank
(KBANK TB) | Company Update
|
Hong Kong Banks
|
Sector Update
|
Sep 2014: LDR remains healthy
|
- Moderate
loan & deposit growth in Sep 2014. Keep NEUTRAL.
- HKD
LDR was
- Easing
HKD funding cost should help stabilize NIM in 2H14.
- (FULL
REPORT WILL BE OUT SOON)
|
Chongqing Rural Commercial Bank
(3618 HK)
|
Best 3Q14 results among peers
|
Share Price: HKD3.73 | Target
Price: HKD4.75 (+27%) | MCap (USD): 4.5B | ADTV (USD): 4M
|
- Maintain
BUY; Raising EPS forecasts with new TP of HKD4.75.
- Room
to maintain strong loan and net fees growth.
- Accumulate
excess provisions; Slow capital consumption.
|
China Auto OEM
|
Sector Update
|
3Q results show signs of
softening
|
- We
expect tougher competition in 4Q and more aggressive price
cuts amid challenging YoY comparison.
- We
continue to like SAIC given its attractive valuation, its
healthy inventory level with stable sales & profit growth.
- Improving
inventory condition along with introduction of fuel efficiency
subsidy will continue to support recovery of select domestic
brands. This offers trading opportunity.
|
MGM China Holdings (2282 HK)
|
Margin growth, mass-market boost
|
Share Price: HKD24.15 | Target
Price: HKD28.95 (+20%) | MCap (USD): 11.8B | ADTV (USD): 19M
|
- Maintain
BUY with HKD28.95 TP as the strong results confirm our
positive view on MGM China.
- 3Q14
EBITDA up 13% YoY, despite VIP volumes dropping. Results
within expectations of our full-year forecast.
- Mass
market revenue up 34% YoY. 15% YoY margin expansion.
|
ICICI Bank (ICICIBC IN)
|
Mixed underlying trends
|
Share Price: INR1,612 | Target
Price: INR1,765 (+10%) | MCap (USD): 30.3B | ADTV (USD): 62M
|
- Maintain
BUY with SOTP-based TP of INR1,765.
- ICICIBC
delivered a mixed set of numbers. Healthy NII growth aided by
margin expansion, steady CASA and retail-loans-driven growth
were positives. While stress in asset quality and weak core
fee income disappointed.
- We
forecast 14% EPS CAGR over FY14-17. Sharp NIM expansion looks
difficult. Higher dividend from subsidiaries and repatriation
income will support earnings. ROE will expand by 140bps to
15.4% on increase in leverage.
|
Yes Bank (YES IN)
|
Fairly priced
|
Share Price: INR663 | Target
Price: INR620 (-6%) | MCap (USD): 4.5B | ADTV (USD): 28M
|
- Maintain
HOLD and raise TP to INR620 based on 1.8x one-year forward
P/BV.
- EPS
grew 11% ahead of estimates on higher-than-expected loan
growth and fee income. Driven by wholesale book, loans grew
strongly at 30% YoY. NIM expansion was on the back of recent
capital infusion.
- We
raise EPS estimates by 3%/2% for FY15/16 to factor in higher
loan growth and NIM. Current valuations of 2.0x FY16E BV
prices in all positives.
- (FULL
NOTE WILL BE OUT SOON)
|
Kalbe Farma (KLBF IJ)
|
9M14 results in line
|
Share Price: IDR1,705 | Target
Price: IDR2,000 (+17%) | MCap (USD): 6.6B | ADTV (USD): 7M
|
- 9M14
net earnings grew 9% y-y to IDR1.5tn, in line with our expectation.
It made up 68% of our FY14F earnings (vs. 9M13 earnings� 71% FY13).
- Pharmaceuticals
and consumer businesses still showed solid revenue growth of
17% y-y (combined). Distribution revenue were flattish (+2%
y-y).
- Retain
Buy on LT growth potential from Indonesia healthcare
development and consumers�
better health awareness.
- (FULL
NOTE WILL BE OUT SOON)
|
ACE Hardware (ACES IJ)
|
9M14 results slightly above
|
Share Price: IDR810 | Target
Price: IDR700 (-14%) | MCap (USD): 1.1B | ADTV (USD): 1M
|
- 9M14
net earnings of IDR376bn (+18% y-y) were slightly above our
expectation. It made up 67% of our FY14F earnings estimates
(vs. 9M13 earnings� 63%
FY13).
- Revenue
grew by 20% y-y to IDR3.4tn while EBIT increased by 22% y-y as
EBIT margin expanded by 30bps vs. 9M13.
- We
retain our cautious view on middle upper segment retail
including ACES, on potential margin pressure from higher wage
increase expected for FY15F and rising competition.
- (FULL
REPORT WILL BE OUT SOON)
|
Gudang Garam (GGRM IJ)
|
Margin improvement continues
|
Share Price: IDR57,750 | Target
Price: IDR75,000 (+30%) | MCap (USD): 9.2B | ADTV (USD): 3M
|
- 9M14
net earnings of IDR4tn (+25% y-y) came slightly above our
expectation. It was driven by strong revenue growth (+20% y-y)
and margin improvement.
- Based
on our observation, GGRM products� ASP has gone up by 7-13%
over 9M14, which suggest overall strong blended volume growth
for the company.
- Upgraded
FY15-16F earnings by 13% respectively and adjusted up our TP
to IDR75,000 (from IDR65,000), which implies 22x PE FY15F
similar to previous TP.
- (FULL
REPORT WILL BE OUT SOON)
|
Indofood CBP (ICBP IJ)
|
Still a tough quarter
|
Share Price: IDR11,050 | Target
Price: IDR12,500 (+13%) | MCap (USD): 5.3B | ADTV (USD): 3M
|
- 9M14
net earnings of IDR2.1tn (+12% y-y) were in line with our
expectation. It made up 80% of our FY14F earnings estimates
(vs. 9M13 earnings� 83%
FY13).
- Revenue
for 9M14 grew by 21% y-y to IDR22.8tn on the back of ASP
increase and addition of new business (beverages). EBIT margin
compressed by 150bps to 10.9%.
- Noodle
remained as the biggest contributor for revenue and EBIT, 66%
and 98% respectively as per 9M14.
- (FULL
REPORT WILL BE OUT SOON)
|
Erajaya Swasembada (ERAA IJ)
|
Inventory pressure easing
|
Share Price: IDR1,020 | Target
Price: IDR1,229 (+20%) | MCap (USD): 245M | ADTV (USD): 2M
|
- 3Q14
below due to higher expenses and financing costs. EPS cut by
15-18%.
- Successfully
working with Samsung to manage sales channels. Inventory back
to more typical levels.
- Maintain
BUY. Lower TP of IDR1,229 from IDR1,449 after EPS cuts, still
at 10x FY15E P/E. Catalysts from continued Indonesian
smartphone adoption.
|
Mitra Adiperkasa (MAPI IJ)
|
9M14 results below
|
Share Price: IDR5,300 | Target
Price: IDR5,500 (+4%) | MCap (USD): 728M | ADTV (USD): 0.8M
|
- 9M14
net earnings of IDR111bn (-51% y-y) was below our expectation.
It only made up 36% of our FY14F earnings estimates (vs. 9M13
earnings� 69% FY13)
- Although
revenue grew a strong 25% y-y to IDR8.7tn, EBIT margin
compressed 340bps to 4.1% mainly due to lower gross margin
from discounting.
- Higher
financing cost (+66% y-y) also contributed to the company�s margin pressure.
- (FULL
REPORT WILL BE OUT SOON)
|
Lippo Karawaci (LPKR IJ)
|
9M14 results below estimates
|
Share Price: IDR1,070 | Target
Price: IDR1,200 (+12%) | MCap (USD): 2.0B | ADTV (USD): 8M
|
- Net
earnings were IDR1t, making up 69% and 62% of our and
consensus FY14 earnings estimates.
- Healthcare
segment continued to be robust at the expense of the property
segment which yields higher margins. EBIT margin for 3Q14 was
on the low side at 20%.
- Maintain
HOLD with TP of IDR1,200 (41% discount to RNAV).
|
Matahari Putra Prima (MPPA IJ)
|
Growth sustained in 3Q14
|
Share Price: IDR3,145 | Target
Price: IDR3,500 (+11%) | MCap (USD): 1.4B | ADTV (USD): 11M
|
- 9M14
core earnings (ex-one off income) of IDR269bn (+110% y-y) were
slightly above our expectation (79% of our FY14F earnings
estimates).
- Gross
revenue for 9M14 grew 15% y-y to IDR10.6tn on the back of 6.7%
SSSG. EBIT margin improved by 110bps to 3.7% vs. 9M13.
- As of
Oct14, MPPA has opened 4 new Hypermart stores, leading to
total store count to 103 outlets.
- (FULL
REPORT WILL BE OUT SOON)
|
Ramayana Lestari (RALS IJ)
|
Flat growth
|
Share Price: IDR810 | Target
Price: IDR1,000 (+23%) | MCap (USD): 476M | ADTV (USD): 0.9M
|
- 9M14
net earnings of IDR340bn (-1% y-y) were in line with our
expectations. It made up 87% of our FY14F earnings estimates
(vs. 9M13 earnings� 88%
FY13).
- Gross
revenue was flat at IDR6.3tn on the back of SSSG of 1.3%. EBIT
margin narrowed by 110bps to 5.3%.
- Reiterate
BUY with TP of IDR1,000 (18x FY15F PER). We expect the company
to benefit from its supermarket restructuring following the
recent partnership with SPAR.
- (FULL
REPORT WILL BE OUT SOON)
|
Tenaga Nasional (TNB MK)
|
A strong finish indeed
|
Share Price: MYR13.36 | Target
Price: MYR16.00 (+20%) | MCap (USD): 22.9B | ADTV (USD): 25M
|
- FY14
core net profit of MYR5.4b (a record-high) was in line with
ours and consensus expectations.
- Positive
earnings outlook as 1) coal generation trends up, 2) coal
prices remain suppressed and 3) tax rate stays low.
- Raising
FY15/16 earnings by 11%/13%, and TP to MYR16.00 (+14%);
reiterate BUY.
|
Malaysia Banking
|
Sector Update
|
Loan growth ticks up in September
|
- Industry
loan growth ticked up to 9% YoY in Sep 2014 (8.6% YoY in Aug)
supported by non-HH loan growth (+6.7% YoY);
- Positively,
interest spreads continue to expand; keeping an eye on
liquidity and consumer asset quality.
- Our
2014 loan growth forecast of 8.7% maintained. NEUTRAL on
sector; BUY RHB, AFG, HL Bank, and HLFG.
|
Felda Global Ventures (FGV MK)
|
Bigger downstream plans in China?
|
Share Price: MYR3.66 | Target
Price: MYR3.97 (+8%) | MCap (USD): 4.1B | ADTV (USD): 2M
|
- FGV
proposal to gain a 100%-control (presently 50%) of its
downstream business in China is positive for the long term.
- Due
to insufficient details, we are unable to assess its financial
impact but we believe it is likely to be marginal.
- Maintain
HOLD with unchanged SOP-based TP of MYR3.97.
|
SMRT (MRT SP)
|
No stock drivers yet
|
Share Price: SGD1.49 | Target
Price: SGD1.36 (-9%) | MCap (USD): 1.8B | ADTV (USD): 1M
|
- 2Q
above on better costs. Fare-based business reverted to
+SGD5.5m EBIT, lifting net income by 76% YoY to SGD25.3m.
- EPS
raised by 82%. Still, stock could stay range-bound in absence
of clarity over rail transition.
- Maintain
HOLD & base-case SGD1.36 TP.
|
Kasikornbank (KBANK TB)
|
Hiking provisions in FY15
|
Share Price: THB233.00 | Target
Price: THB265.00 (+14%) | MCap (USD): 17.1B | ADTV (USD): 32M
|
- Maintain
BUY with THB265 TP, implying 2.1x 2015 P/BV and 19% ROE.
- Expect
better loan growth and NIM next year; see upside risk on
dividend payout ratio next few years.
- Raise
2014 earnings by 2.6% to reflect better NIM and cut 2015
earnings by 1.4% on higher credit cost.
|
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.